Trial intelligence / Profile preview

FORWARD: n-3 PUFA for Maintenance of Sinus Rhythm in Persistent AF

NCT00597220Phase 3Unknown

Sponsor
Fundación GESICA
Start
Jan 2008
Primary completion
Jul 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of omega-3 fatty acid in Atrial fibrillation (AFib), sponsored by Fundación GESICA. Status: unknown.

02

Drugs

omega-3 fatty acid
03

Conditions

Atrial fibrillation (AFib)

Beyond the preview

Go deeper on NCT00597220.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00597220.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call